. Long acting bupivacaine liposome injectable suspension. OrthopaedicsOne Articles. In: OrthopaedicsOne - The Orthopaedic Knowledge Network. Created Mar 09, 2013 18:19. Last modified Mar 09, 2013 19:44 ver.5. Retrieved 2019-10-18, from https://www.orthopaedicsone.com/x/MoD9BQ.
Explore a Novel Option for Postoperative Pain Control
John Barrington, MD, demonstrates the use of a novel long-acting bupivacaine liposome injectable suspension (EXPAREL®; Pacira, Parsippany, New Jersey) to manage the discomfort his patients experience following major joint replacement surgery.
The videos feature Dr. Barrington explaining how he infiltrates the wound site with EXPAREL during knee and hip replacement procedures. He prefers EXPAREL as part of his multimodal pain management strategy because it controls pain for up to 72 hours postoperatively.
 | Infiltration Technique - Partial Knee Arthroplasty This video demonstrates the infiltration technique of a non-opioid local analgesic indicated for administration into the surgical site to produce postsurgical analgesia in a partial knee arthroplasty |
|---|---|
 | Infiltration Technique - Total Hip Arthroplasty with Anterior Approach This video demonstrates the infiltration technique of a non-opioid local analgesic indicated for administration into the surgical site to produce postsurgical analgesia in a total hip arthroplasty using the anterior approach |
 | Live Surgery - Total Hip Arthroplasty with Anterior Approach This video demonstrates a total hip arthroplasty using the anterior approach along with the infiltration technique of a long acting non-opioid local analgesic indicated for administration into the surgical site to produce postsurgical analgesia |
 | Live Surgery - Oxford Partial Knee Arthroplasty This video demonstrates an Oxford partial knee arthroplasty which includes the infiltration technique of a long acting non-opioid local analgesic indicated for administration into the surgical site to produce postsurgical analgesia |
About Pacira
Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam® drug delivery technology, for use in hospitals and ambulatory surgery centers. Learn more at www.pacira.com.
